PJP logo

Invesco Dynamic Pharmaceuticals ETF (PJP)

$128.87

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PJP

AUM

$574760200

P/E ratio

23.1

Dividend yield

0.8764%

Expense ratio

0.58%

Beta

0.433852

Price on PJP

Previous close

$129.86

Today's open

$128.86

Day's range

$128.42 - $129.44

52 week range

$99.05 - $132.59

Profile about PJP

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

PJP industries and sectors

Industries

Health

News on PJP

PJP: Healthcare Sector Dashboard For November

The healthcare equipment industry is undervalued based on historical averages, while pharma/biotechnology is significantly overvalued. Invesco Pharmaceuticals ETF (PJP) offers multi-factor pharmaceutical exposure suited to long-term and tactical allocations. PJP outperformed the sector benchmark XLV since inception and over the past 12 months, but lagged it from July 2015 to July 2025.

news source

Seeking Alpha • Nov 17, 2026

news preview

Better Healthcare ETF: Invesco's PJP vs. Simplify's PINK

The Invesco Pharmaceuticals ETF has delivered significantly higher 1-year total returns than the Simplify Health Care ETF. The Simplify Health Care ETF operates with a lower expense ratio and follows a unique pro bono model that supports breast cancer research.

news source

The Motley Fool • Nov 16, 2026

news preview

The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

iShares Global Healthcare ETF features a lower expense ratio and a higher dividend yield than Invesco Pharmaceuticals ETF. Invesco Pharmaceuticals ETF provides concentrated exposure to 28 U.S. drugmakers, whereas iShares Global Healthcare ETF holds 109 global positions.

news source

The Motley Fool • Nov 7, 2026

news preview

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on June 23, 2005.

news source

Zacks Investment Research • Nov 3, 2026

news preview

How to Invest in the Rise of China's Biotech: Buy U.S. Drug Stocks

Many of the hot new drug candidates in the U.S. were developed Chinese companies.

news source

Barrons • Nov 3, 2026

news preview

Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens

The Invesco S&P 500 Equal Weight Health Care ETF offers a lower expense ratio and broader diversification than the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has generated higher 1-year and 5-year total returns while maintaining lower price volatility.

news source

The Motley Fool • Oct 11, 2026

news preview

Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP

The VanEck Pharmaceutical ETF offers a lower expense ratio of 0.36% compared to 0.58% for the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has delivered a higher 1-year total return of 41% relative to 31% for the VanEck fund.

news source

The Motley Fool • Oct 3, 2026

news preview

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

news source

Zacks Investment Research • Sep 28, 2026

news preview

XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks

The State Street Health Care Select Sector SPDR ETF (XLV) offers significantly lower ownership costs, with an expense ratio of 0.08% compared to 0.58% for the Invesco Pharmaceuticals ETF (PJP). PJP provides concentrated exposure to 28 pharmaceutical stocks, while XLV holds 61 diversified healthcare companies.

news source

The Motley Fool • Sep 23, 2026

news preview

FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?

Fidelity MSCI Health Care Index ETF (FHLC) offers a significantly lower expense ratio and a higher dividend yield than the Invesco Pharmaceuticals ETF (PJP). PJP provides a concentrated portfolio of just over 30 pharmaceutical stocks, while FHLC diversifies across more than 300 holdings.

news source

The Motley Fool • Aug 23, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Invesco Dynamic Pharmaceuticals ETF

Open an M1 investment account to buy and sell Invesco Dynamic Pharmaceuticals ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PJP on M1